Clinical Trials Browser

Phase 1/2 × NETWORK × Busulfan × Clear all

NCT00887042 2012-03-26

Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute